Shares of Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) traded down 1.5% during mid-day trading on Thursday . The company traded as low as $4.51 and last traded at $4.57. 2,867,074 shares were traded during trading, a decline of 33% from the average session volume of 4,280,556 shares. The stock had previously closed at $4.64.
Analysts Set New Price Targets
Several research analysts recently issued reports on the company. Weiss Ratings raised Tilray Brands from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Monday. TD Cowen lowered their price target on Tilray Brands from $7.00 to $5.00 and set a "buy" rating for the company in a report on Tuesday, July 14th. TD Securities upgraded Tilray Brands to a "strong-buy" rating in a research note on Friday, July 31st. Finally, Wall Street Zen downgraded shares of Tilray Brands from a "hold" rating to a "sell" rating in a report on Saturday, August 1st. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $8.00.
Get Our Latest Stock Report on TLRY
Tilray Brands Trading Down 1.5%
The stock has a market cap of $622.45 million, a PE ratio of -4.23 and a beta of 1.90. The company's fifty day moving average is $4.47 and its 200-day moving average is $5.74. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.21 and a quick ratio of 1.37.
Tilray Brands (NASDAQ:TLRY - Get Free Report) last posted its earnings results on Tuesday, July 28th. The company reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.42). Tilray Brands had a negative return on equity of 7.76% and a negative net margin of 13.11%.The company had revenue of $281.71 million for the quarter, compared to analyst estimates of $246.30 million. On average, analysts predict that Tilray Brands, Inc. will post -0.42 earnings per share for the current fiscal year.
Insider Buying and Selling at Tilray Brands
In other news, CFO Carl A. Merton acquired 10,000 shares of the firm's stock in a transaction on Tuesday, August 4th. The shares were bought at an average price of $4.62 per share, for a total transaction of $46,200.00. Following the acquisition, the chief financial officer owned 139,753 shares of the company's stock, valued at approximately $645,658.86. This trade represents a 7.71% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Insiders purchased a total of 15,000 shares of company stock valued at $69,225 in the last quarter. Company insiders own 0.84% of the company's stock.
Institutional Investors Weigh In On Tilray Brands
A number of hedge funds have recently modified their holdings of the company. Amundi purchased a new stake in shares of Tilray Brands in the 2nd quarter valued at approximately $131,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Tilray Brands in the second quarter valued at approximately $75,000. California State Teachers Retirement System grew its position in Tilray Brands by 440.6% in the second quarter. California State Teachers Retirement System now owns 546,518 shares of the company's stock worth $2,454,000 after acquiring an additional 445,414 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Tilray Brands by 6.1% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 208,229 shares of the company's stock worth $935,000 after acquiring an additional 11,894 shares during the last quarter. Finally, Hsbc Holdings PLC acquired a new stake in Tilray Brands during the second quarter worth $182,000. Hedge funds and other institutional investors own 9.35% of the company's stock.
About Tilray Brands
(
Get Free Report)
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
